Ligand Pharmaceuticals
LGND
#3635
Rank
S$4.65 B
Marketcap
S$236.55
Share price
-0.49%
Change (1 day)
46.35%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.68 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are S$0.68 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.15 B32.77%
2023-12-31S$0.11 B-48.53%
2022-12-31S$0.22 B-65.62%
2021-12-31S$0.64 B-25.41%
2020-12-31S$0.86 B-11.98%
2019-12-31S$0.98 B2.6%
2018-12-31S$0.95 B183.26%
2017-12-31S$0.33 B1.08%
2016-12-31S$0.33 B4.39%
2015-12-31S$0.31 B3.63%
2014-12-31S$0.30 B342.19%
2013-12-31S$69.81 M-26.6%
2012-12-31S$95.11 M-34.66%
2011-12-31S$0.14 B40.54%
2010-12-31S$0.10 B-46.56%
2009-12-31S$0.19 B-25.45%
2008-12-31S$0.26 B25.34%
2007-12-31S$0.20 B-54.71%
2006-12-31S$0.45 B-35.28%
2005-12-31S$0.70 B6.38%
2004-12-31S$0.66 B11.36%
2003-12-31S$0.59 B70.93%
2002-12-31S$0.34 B7.66%
2001-12-31S$0.32 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
S$104.01 B 15,190.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S$0.10 B-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$79.16 B 11,537.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$100.28 B 14,643.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.36 B 21,858.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$117.65 B 17,196.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.12 B 14,766.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$17.89 B 2,530.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$146.65 B 21,460.73%๐Ÿ‡บ๐Ÿ‡ธ USA